QUANTERIX CORP (QTRX) Stock Price & Overview

NASDAQ:QTRX • US74766Q1013

4.76 USD
-0.25 (-4.99%)
At close: Mar 12, 2026
4.76 USD
0 (0%)
After Hours: 3/12/2026, 8:06:33 PM

The current stock price of QTRX is 4.76 USD. Today QTRX is down by -4.99%. In the past month the price decreased by -20.4%. In the past year, price decreased by -32.58%.

QTRX Key Statistics

52-Week Range4.05 - 8.77
Current QTRX stock price positioned within its 52-week range.
1-Month Range4.75 - 6.81
Current QTRX stock price positioned within its 1-month range.
Market Cap
222.34M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-2.21
Dividend Yield
N/A

QTRX Stock Performance

Today
-4.99%
1 Week
-10.36%
1 Month
-20.40%
3 Months
-37.04%
Longer-term
6 Months -1.04%
1 Year -32.58%
2 Years -79.80%
3 Years -57.76%
5 Years -91.86%
10 Years N/A

QTRX Stock Chart

QUANTERIX CORP / QTRX Daily stock chart

QTRX Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to QTRX. When comparing the yearly performance of all stocks, QTRX is a bad performer in the overall market: 90.45% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
QTRX Full Technical Analysis Report

QTRX Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to QTRX. The financial health of QTRX is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
QTRX Full Fundamental Analysis Report

QTRX Earnings

On March 2, 2026 QTRX reported an EPS of -0.49 and a revenue of 43.85M. The company missed EPS expectations (-6.75% surprise) and beat revenue expectations (12.73% surprise).

Next Earnings DateMay 11, 2026
Last Earnings DateMar 2, 2026
PeriodQ4 / 2025
EPS Reported-$0.49
Revenue Reported43.855M
EPS Surprise -6.75%
Revenue Surprise 12.73%
QTRX Earnings History

QTRX Forecast & Estimates

9 analysts have analysed QTRX and the average price target is 7.65 USD. This implies a price increase of 60.71% is expected in the next year compared to the current price of 4.76.

For the next year, analysts expect an EPS growth of 39.08% and a revenue growth 28.28% for QTRX


Analysts
Analysts48.89
Price Target7.65 (60.71%)
EPS Next Y39.08%
Revenue Next Year28.28%
QTRX Forecast & Estimates

QTRX Groups

Sector & Classification

QTRX Financial Highlights

Over the last trailing twelve months QTRX reported a non-GAAP Earnings per Share(EPS) of -2.21. The EPS decreased by -114.56% compared to the year before.


Income Statements
Revenue(TTM)138.90M
Net Income(TTM)-107.15M
Industry RankSector Rank
PM (TTM) N/A
ROA -25.59%
ROE -36.23%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-63.33%
Sales Q2Q%24.72%
EPS 1Y (TTM)-114.56%
Revenue 1Y (TTM)-18.05%
QTRX financials

QTRX Ownership

Ownership
Inst Owners78.17%
Shares46.71M
Float41.22M
Ins Owners0.91%
Short Float %9.48%
Short Ratio6.01
QTRX Ownership

QTRX Latest News, Press Relases and Analysis

All QTRX news

QTRX Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
TMO THERMO FISHER SCIENTIFIC INC19.19184.15B
DHR DANAHER CORP21.93137.935B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28130.8444.512B
A AGILENT TECHNOLOGIES INC16.6832.629B
WAT WATERS CORP19.529.189B
IQV IQVIA HOLDINGS INC12.7128.803B
MTD METTLER-TOLEDO INTERNATIONAL24.924.984B
ILMN ILLUMINA INC22.0918.577B
WST WEST PHARMACEUTICAL SERVICES28.5217.159B
MEDP MEDPACE HOLDINGS INC25.4613.558B
RVTY REVVITY INC15.3710.021B
TEM TEMPUS AI INC-CL A N/A9.418B
TECH BIO-TECHNE CORP23.138.389B

About QTRX

Company Profile

QTRX logo image Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 471 full-time employees. The company went IPO on 2017-12-07. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

Company Info

IPO: 2017-12-07

QUANTERIX CORP

900 Middlesex Turnpike

Billerica MASSACHUSETTS 01821 US

CEO: E. Kevin Hrusovsky

Employees: 471

QTRX Company Website

QTRX Investor Relations

Phone: 13026587581

QUANTERIX CORP / QTRX FAQ

Can you describe the business of QUANTERIX CORP?

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 471 full-time employees. The company went IPO on 2017-12-07. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.


What is the current price of QTRX stock?

The current stock price of QTRX is 4.76 USD. The price decreased by -4.99% in the last trading session.


Does QTRX stock pay dividends?

QTRX does not pay a dividend.


What is the ChartMill rating of QUANTERIX CORP stock?

QTRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


On which exchange is QTRX stock listed?

QTRX stock is listed on the Nasdaq exchange.


What is the Price/Earnings (PE) ratio of QUANTERIX CORP (QTRX)?

QUANTERIX CORP (QTRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.21).


What is QUANTERIX CORP worth?

QUANTERIX CORP (QTRX) has a market capitalization of 222.34M USD. This makes QTRX a Micro Cap stock.